Charles Cheyney

Array ( [id] => 4130044 [patent_doc_number] => 06127550 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-10-03 [patent_title] => 'Stereospecific preparation of chiral 1-aryl-and 1-heteroaryl-2-substituted ethyl-2-amines' [patent_app_type] => 1 [patent_app_number] => 9/266641 [patent_app_country] => US [patent_app_date] => 1999-03-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2975 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 108 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/127/06127550.pdf [firstpage_image] =>[orig_patent_app_number] => 266641 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4147685 [patent_doc_number] => 06063804 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-05-16 [patent_title] => 'Pyrrole compounds' [patent_app_type] => 1 [patent_app_number] => 9/199640 [patent_app_country] => US [patent_app_date] => 1998-11-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7924 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 771 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/063/06063804.pdf [firstpage_image] =>[orig_patent_app_number] => 199640 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3933820 [patent_doc_number] => 05939417 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-08-17 [patent_title] => '1,3,6-trihydro-6-aza-3-oxapentalen-2-one derivatives for the treatment of neoplasia' [patent_app_type] => 1 [patent_app_number] => 9/174815 [patent_app_country] => US [patent_app_date] => 1998-10-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 39649 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 195 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/939/05939417.pdf [firstpage_image] =>[orig_patent_app_number] => 174815 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4087948 [patent_doc_number] => 06017945 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-01-25 [patent_title] => 'Indole derivatives useful as endothelin receptor antagonists' [patent_app_type] => 1 [patent_app_number] => 9/147096 [patent_app_country] => US [patent_app_date] => 1998-10-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29517 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 610 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/017/06017945.pdf [firstpage_image] =>[orig_patent_app_number] => 147096 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4011060 [patent_doc_number] => 05962504 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-10-05 [patent_title] => 'Substituted 2-pyrrolidinone activators of PKC' [patent_app_type] => 1 [patent_app_number] => 9/149609 [patent_app_country] => US [patent_app_date] => 1998-09-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 18655 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/962/05962504.pdf [firstpage_image] =>[orig_patent_app_number] => 149609 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4035208 [patent_doc_number] => 05994559 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-30 [patent_title] => 'Synthesis of monatin-A high intensity natural sweetener' [patent_app_type] => 1 [patent_app_number] => 9/131085 [patent_app_country] => US [patent_app_date] => 1998-08-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2716 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 86 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/994/05994559.pdf [firstpage_image] =>[orig_patent_app_number] => 131085 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4179907 [patent_doc_number] => 06037362 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-03-14 [patent_title] => 'Tricyclic compounds and drug compositions containing the same' [patent_app_type] => 1 [patent_app_number] => 9/101232 [patent_app_country] => US [patent_app_date] => 1998-08-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 63536 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 95 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/037/06037362.pdf [firstpage_image] =>[orig_patent_app_number] => 101232 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4049435 [patent_doc_number] => 05968971 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-10-19 [patent_title] => 'Endothelin receptor antagonists' [patent_app_type] => 1 [patent_app_number] => 9/117555 [patent_app_country] => US [patent_app_date] => 1998-07-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3977 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 1025 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/968/05968971.pdf [firstpage_image] =>[orig_patent_app_number] => 117555 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4077789 [patent_doc_number] => 05965753 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-10-12 [patent_title] => 'Process for preparation of glycidyl sulfonate derivative' [patent_app_type] => 1 [patent_app_number] => 9/101878 [patent_app_country] => US [patent_app_date] => 1998-07-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3851 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 95 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/965/05965753.pdf [firstpage_image] =>[orig_patent_app_number] => 101878 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4192953 [patent_doc_number] => 06130238 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-10-10 [patent_title] => '3-(cyclohexanoheteroarylidenyl)-2-indolinone protein tyrosine kinase inhibitors' [patent_app_type] => 1 [patent_app_number] => 9/099842 [patent_app_country] => US [patent_app_date] => 1998-06-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 55682 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/130/06130238.pdf [firstpage_image] =>[orig_patent_app_number] => 099842 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3941324 [patent_doc_number] => 05973178 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-10-26 [patent_title] => 'Dye intermediates' [patent_app_type] => 1 [patent_app_number] => 9/077217 [patent_app_country] => US [patent_app_date] => 1998-05-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1906 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 111 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/973/05973178.pdf [firstpage_image] =>[orig_patent_app_number] => 077217 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3944540 [patent_doc_number] => 05990151 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-23 [patent_title] => 'Optically active substituted phenylalkylamine derivatives' [patent_app_type] => 1 [patent_app_number] => 8/981539 [patent_app_country] => US [patent_app_date] => 1998-05-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6098 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 118 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/990/05990151.pdf [firstpage_image] =>[orig_patent_app_number] => 981539 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3947259 [patent_doc_number] => 05998459 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-12-07 [patent_title] => 'Pyrrole derivatives and medicinal composition' [patent_app_type] => 1 [patent_app_number] => 8/973369 [patent_app_country] => US [patent_app_date] => 1997-12-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20236 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 477 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/998/05998459.pdf [firstpage_image] =>[orig_patent_app_number] => 973369 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4066529 [patent_doc_number] => 06008257 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-12-28 [patent_title] => 'Hydroxamic-acid derivatives, method of preparing them and their use as fungicides' [patent_app_type] => 1 [patent_app_number] => 8/916045 [patent_app_country] => US [patent_app_date] => 1997-08-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8263 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 340 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/008/06008257.pdf [firstpage_image] =>[orig_patent_app_number] => 916045 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4141363 [patent_doc_number] => 06060492 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-05-09 [patent_title] => 'Selective .beta.3 adrenergic agonists' [patent_app_type] => 1 [patent_app_number] => 8/882587 [patent_app_country] => US [patent_app_date] => 1997-06-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18632 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 589 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/060/06060492.pdf [firstpage_image] =>[orig_patent_app_number] => 882587 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3934208 [patent_doc_number] => 05939443 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-08-17 [patent_title] => 'Selective .beta.3 adrenergic agonists' [patent_app_type] => 1 [patent_app_number] => 8/882503 [patent_app_country] => US [patent_app_date] => 1997-06-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18817 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 548 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/939/05939443.pdf [firstpage_image] =>[orig_patent_app_number] => 882503 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4086487 [patent_doc_number] => 06025355 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-02-15 [patent_title] => 'Pharmaceutically active compounds and methods of use' [patent_app_type] => 1 [patent_app_number] => 8/858399 [patent_app_country] => US [patent_app_date] => 1997-05-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21759 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 32 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/025/06025355.pdf [firstpage_image] =>[orig_patent_app_number] => 858399 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4016604 [patent_doc_number] => 05880288 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-03-09 [patent_title] => 'Process for the preparation of 2-methylthiazole-5-carboxylates' [patent_app_type] => 1 [patent_app_number] => 7/927981 [patent_app_country] => US [patent_app_date] => 1992-08-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1156 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/880/05880288.pdf [firstpage_image] =>[orig_patent_app_number] => 927981 [rel_patent_id] =>[rel_patent_doc_number] =>)